NRIX PEER ANALYSIS

Nurix Therapeutics Inc — metric-by-metric comparison with peers and the industry median

NRIXNurix Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

NRIXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	NRIX	TLX	MSB	CSL	Ind. Median
P/E	—	—	—	29.96	18.06
P/B	5.58	6.38	—	2.24●	3.62
EV/EBITDA	—	120.20	—	10.35●	15.13
P/S	37.42	3.24	31.30	2.66●	10.65

Financial Health
Metric	NRIX	TLX	MSB	CSL	Ind. Median
Current Ratio	6.01●	1.43	—	2.57	5.90
Debt/Equity	12.2%●	112.3%	—	67.4%	10.9%
NetDebt/EBITDA	1.76●	13.13	—	2.22	1.15

Profitability
Metric	NRIX	TLX	MSB	CSL	Ind. Median
Net Margin	-411.4%	-0.9%	-115.3%	9.2%●	-125.7%
ROE	-61.4%	-1.8%	-11.3%	7.7%●	-47.5%
ROA	-47.2%	-0.7%	-8.6%	3.8%●	-35.8%
EBITDA Margin	-382.1%	3.0%	-76.6%	32.8%●	-105.8%

Growth + Dividend
Metric	NRIX	TLX	MSB	CSL	Ind. Median
Rev. Growth	27.2%	56.3%	410.4%●	4.8%	5.1%
NI Growth	—	—	—	-39.4%	12.1%
Div. Yield	—	—	0.0%	2.5%●	0.2%
Payout	—	—	0.0%	103.1%	0.0%

Valuation
Metric	NRIX	TRVI	COGT	CLDX	TARS	VCEL	Ind. Median
P/E	—	—	—	—	—	111.07	18.06
P/B	5.58	16.49	4.44●	5.83	8.68	6.69	3.62
EV/EBITDA	—	—	—	—	—	66.16	15.13
P/S	37.42	—	—	3,241.44	5.66●	8.16	10.65

Financial Health
Metric	NRIX	TRVI	COGT	CLDX	TARS	VCEL	Ind. Median
Current Ratio	6.01	24.75●	15.14	8.92	3.74	5.18	5.90
Debt/Equity	12.2%	0.4%●	39.3%	0.4%	25.4%	26.5%	10.9%
NetDebt/EBITDA	1.76	3.76	1.79	1.60	7.47	-1.44●	1.15

Profitability
Metric	NRIX	TRVI	COGT	CLDX	TARS	VCEL	Ind. Median
Net Margin	-411.4%	—	—	-34,596.2%	-9.0%	7.3%●	-125.7%
ROE	-61.4%	-33.6%	-85.7%	-48.9%	-14.0%	6.6%●	-47.5%
ROA	-47.2%	-31.8%	-59.7%	-45.4%	-8.9%	4.7%●	-35.8%
EBITDA Margin	-382.1%	—	—	-34,185.6%	-7.5%	12.1%●	-105.8%

Growth + Dividend
Metric	NRIX	TRVI	COGT	CLDX	TARS	VCEL	Ind. Median
Rev. Growth	27.2%	-100.0%	-100.0%	-89.2%	129.0%●	22.4%	5.1%
NI Growth	—	—	—	—	—	620.7%	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on NRIX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.